Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

The Lucid Winter Summit 2016

Press Releases | December 20, 2016 | Lucid Group Communications Limited

Lucid Group put their skates on this year to celebrate an outstanding year’s performance at the Lucid Winter Summit at Somerset House, London.  Lucid Group enter their tenth year of...

How can the NHS deliver integrated care?

White Papers and Resources | December 19, 2016 | Wilmington Healthcare

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain the changes needed to help the NHS provide a more holistic, joined up experience for patients

A Bitter Pill?

White Papers and Resources | December 14, 2016 | Inizio

The ideal route of admin isn’t clear cut in the global marketplace

2017: Medical education that improves value and outcomes for patients

Press Releases | December 12, 2016 | Lucid Group Communications Limited

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

How can pharma engage with NHS Vanguards?

White Papers and Resources | December 12, 2016 | Wilmington Healthcare

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.

Webinar: Become your customer’s chosen channel

White Papers and Resources | December 8, 2016 | Anthill Agency

Your customer now expects to access knowledge in any format and at any time that they desire. But how do you become the ever-present partner that they trust and value...

Understanding the chronic disease patient journey in emerging markets

White Papers and Resources | December 7, 2016 | Inizio

In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these...

Infographic: Keeping tracking on track

White Papers and Resources | December 7, 2016 | Inizio

Our best practice approach to tracking studies.

Lucid Group kick off their Winter Festival

Press Releases | December 6, 2016 | Lucid Group Communications Limited

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

What does the Five Year Forward View mean for pharma?

White Papers and Resources | December 6, 2016 | Wilmington Healthcare

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.